Manufacturer of Controlled Substances; Notice of Registration; Alltech Associates, Inc., 33443 [2013-13228]

Download as PDF 33443 Federal Register / Vol. 78, No. 107 / Tuesday, June 4, 2013 / Notices 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: May 24, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–13230 Filed 6–3–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Pharmagra Labs, Inc. By Notice dated February 8, 2013, and published in the Federal Register on February 21, 2013, 78 FR 12102, Pharmagra Labs, Inc., 158 McLean Road, Brevard, North Carolina 28712, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Pentobarbital (2270), a basic class of controlled substance in schedule II. The company plans to manufacture the listed substance for analytical research and clinical trials. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a), and determined that the registration of Pharmagra Labs, Inc., to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Pharmagra Labs., Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: May 24, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–13227 Filed 6–3–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Alltech Associates, Inc. By Notice dated February 8, 2013 and published in the Federal Register on February 21, 2013, 78 FR 12103, Alltech Associates, Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule tkelley on DSK3SPTVN1PROD with NOTICES 5-Methoxy-N-N-dimethyltryptamine (7431) ................................................................................................................................................. 2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine) (7509) ....................................................................................................................... 2C-H (2-(2,5-Dimethoxyphenyl)ethanamine) (7517) ................................................................................................................................... 2C-T-4 (2-(4-isopropylthio)-2,5-dimethoxyphenyl) ethanamine) (7532) ...................................................................................................... The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Alltech Associates, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Alltech Associates, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: May 24, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. 18:33 Jun 03, 2013 Jkt 229001 Methamphetamine (1105) ............ Pentobarbital (2270) ..................... Nabilone (7379) ............................ Schedule II II II [FR Doc. 2013–13228 Filed 6–3–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Norac, Inc. By Notice dated November 19, 2012, and published in the Federal Register on November 27, 2012, 77 FR 70825, Norac, Inc., DBA: Norac Pharma, 405 S. Motor Avenue, Azusa, California 91702–3232, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Gamma Hydroxybutyric Acid (2010). Tetrahydrocannabinols (7370) ..... VerDate Mar<15>2010 Drug I I I I PO 00000 Frm 00119 Fmt 4703 Sfmt 4703 I I With regard to Gamma Hydroxybutyric Acid (2010), Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the company manufactures these controlled substances in bulk solely for domestic distribution within the United States to customers engaged in dosage-form manufacturing. With regard to Nabilone (7379) only, the company presently manufactures a small amount of this controlled substance in bulk solely to conduct manufacturing internal process development. It is the company’s intention once the manufacturing process is refined to the point that its Nabilone bulk product is available for commercial use, the company will export the controlled substance in bulk solely to customers engaged in dosageform manufacturing outside the United States. The company is aware of the requirement to obtain a DEA registration as an exporter to conduct this activity. E:\FR\FM\04JNN1.SGM 04JNN1

Agencies

[Federal Register Volume 78, Number 107 (Tuesday, June 4, 2013)]
[Notices]
[Page 33443]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13228]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Alltech Associates, Inc.

    By Notice dated February 8, 2013 and published in the Federal 
Register on February 21, 2013, 78 FR 12103, Alltech Associates, Inc., 
2051 Waukegan Road, Deerfield, Illinois 60015, made application to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
5-Methoxy-N-N-dimethyltryptamine (7431).....  I
2C-E (2-(2,5-Dimethoxy-4-                     I
 ethylphenyl)ethanamine) (7509).
2C-H (2-(2,5-Dimethoxyphenyl)ethanamine)      I
 (7517).
2C-T-4 (2-(4-isopropylthio)-2,5-              I
 dimethoxyphenyl) ethanamine) (7532).
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical applications only in clinical, toxicological, and 
forensic laboratories.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Alltech Associates, Inc., to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Alltech Associates, Inc., to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-13228 Filed 6-3-13; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.